TY - JOUR
T1 - The fate of cranial neuropathy after flw diversion for carotid aneurysms
AU - Brown, Benjamin L.
AU - Lopes, Demetrius
AU - Miller, David A.
AU - Tawk, Rabih G.
AU - Brasiliense, Leonardo B.C.
AU - Ringer, Andrew
AU - Sauvageau, Eric
AU - Powers, Ciaran J.
AU - Arthur, Adam
AU - Hoit, Daniel
AU - Snyder, Kenneth
AU - Siddiqui, Adnan
AU - Levy, Elad
AU - Nelson Hopkins, L.
AU - Cuellar, Hugo
AU - Rodriguez-Mercado, Rafael
AU - Veznedaroglu, Erol
AU - Binning, Mandy
AU - Mocco, J.
AU - Aguilar-Salinas, Pedro
AU - Boulos, Alan
AU - Yamamoto, Junichi
AU - Hanel, Ricardo A.
N1 - Funding Information:
Dr. Siddiqui receives research grants from the NIH and the University at Buffalo (not related to the current work).
PY - 2016/4
Y1 - 2016/4
N2 - Objective The authors sought to determine whether flw diversion with the Pipeline Embolization Device (PED) can approximate microsurgical decompression in restoring function after cranial neuropathy following carotid artery aneurysms. methods This multiinstitutional retrospective study involved 45 patients treated with PED across the United States. All patients included presented between November 2009 and October 2013 with cranial neuropathy (cranial nerves [CNs] II, III, IV, and VI) due to intracranial aneurysm. Outcome analysis included clinical and procedural variables at the time of treatment as well as at the latest clinical and radiographic follow-up. results Twenty-six aneurysms (57.8%) were located in the cavernous segment, while 6 (13.3%) were in the clinoid segment, and 13 (28.9%) were in the ophthalmic segment of the internal carotid artery. The average aneurysm size was 18.6 mm (range 4-35 mm), and the average number of flw diverters placed per patient was 1.2. Thirty-eight patients had available information regarding duration of cranial neuropathy prior to treatment. Eleven patients (28.9%) were treated within 1 month of symptom onset, while 27 (71.1%) were treated after 1 month of symptoms. The overall rate of cranial neuropathy improvement for all patients was 66.7%. The CN defiits resolved in 19 patients (42.2%), improved in 11 (24.4%), were unchanged in 14 (31.1%), and worsened in 1 (2.2%). Over time, the rate of cranial neuropathy improvement was 33.3% (15/45), 68.8% (22/32), and 81.0% (17/21) at less than 6, 6, and 12 months, respectively. At last follow-up, 60% of patients in the isolated CN II group had improvement, while in the CN III, IV, or VI group, 85.7% had improved. Moreover, 100% (11/11) of patients experienced improvement if they were treated within 1 month of symptom onset, whereas 44.4% (12/27) experienced improvement if they treated after 1 month of symptom onset; 70.4% (19/27) of those with partial defiits improved compared with 30% (3/10) of those with complete defiits. coNclusioNs Cranial neuropathy caused by cerebral aneurysm responds similarly when the aneurysm is treated with the PED compared with open surgery and coil embolization. Lower morbidity and higher occlusion rates obtained with the PED may suggest it as treatment of choice for some of these lesions. Time to treatment is an important consideration regardless of treatment modality.
AB - Objective The authors sought to determine whether flw diversion with the Pipeline Embolization Device (PED) can approximate microsurgical decompression in restoring function after cranial neuropathy following carotid artery aneurysms. methods This multiinstitutional retrospective study involved 45 patients treated with PED across the United States. All patients included presented between November 2009 and October 2013 with cranial neuropathy (cranial nerves [CNs] II, III, IV, and VI) due to intracranial aneurysm. Outcome analysis included clinical and procedural variables at the time of treatment as well as at the latest clinical and radiographic follow-up. results Twenty-six aneurysms (57.8%) were located in the cavernous segment, while 6 (13.3%) were in the clinoid segment, and 13 (28.9%) were in the ophthalmic segment of the internal carotid artery. The average aneurysm size was 18.6 mm (range 4-35 mm), and the average number of flw diverters placed per patient was 1.2. Thirty-eight patients had available information regarding duration of cranial neuropathy prior to treatment. Eleven patients (28.9%) were treated within 1 month of symptom onset, while 27 (71.1%) were treated after 1 month of symptoms. The overall rate of cranial neuropathy improvement for all patients was 66.7%. The CN defiits resolved in 19 patients (42.2%), improved in 11 (24.4%), were unchanged in 14 (31.1%), and worsened in 1 (2.2%). Over time, the rate of cranial neuropathy improvement was 33.3% (15/45), 68.8% (22/32), and 81.0% (17/21) at less than 6, 6, and 12 months, respectively. At last follow-up, 60% of patients in the isolated CN II group had improvement, while in the CN III, IV, or VI group, 85.7% had improved. Moreover, 100% (11/11) of patients experienced improvement if they were treated within 1 month of symptom onset, whereas 44.4% (12/27) experienced improvement if they treated after 1 month of symptom onset; 70.4% (19/27) of those with partial defiits improved compared with 30% (3/10) of those with complete defiits. coNclusioNs Cranial neuropathy caused by cerebral aneurysm responds similarly when the aneurysm is treated with the PED compared with open surgery and coil embolization. Lower morbidity and higher occlusion rates obtained with the PED may suggest it as treatment of choice for some of these lesions. Time to treatment is an important consideration regardless of treatment modality.
KW - Aneurysm
KW - Cranial neuropathy
KW - Flow diversion
KW - Pipeline Embolization Device
KW - Vascular disorders
UR - http://www.scopus.com/inward/record.url?scp=84975231486&partnerID=8YFLogxK
U2 - 10.3171/2015.4.JNS142790
DO - 10.3171/2015.4.JNS142790
M3 - Article
C2 - 26473786
AN - SCOPUS:84975231486
SN - 0022-3085
VL - 124
SP - 1107
EP - 1113
JO - Journal of Neurosurgery
JF - Journal of Neurosurgery
IS - 4
ER -